(FM) Patología, Anatomía y Fisiología
Departamento académico
Universidad de Oviedo
Oviedo, EspañaUniversidad de Oviedo-ko ikertzaileekin lankidetzan egindako argitalpenak (23)
2020
-
Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates
Brain Structure and Function, Vol. 225, Núm. 7, pp. 2153-2164
-
Expression of cannabinoid CB1R–GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum
Annals of the New York Academy of Sciences, Vol. 1475, Núm. 1, pp. 34-42
2019
-
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Molecular Neurobiology, Vol. 56, Núm. 8, pp. 5900-5910
-
The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042
Journal of Clinical Medicine, Vol. 8, Núm. 8
2018
-
Cancertool: A visualization and representation interface to exploit cancer datasets
Cancer Research, Vol. 78, Núm. 21, pp. 6320-6328
-
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781
2017
-
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors
Frontiers in Pharmacology, Vol. 8, Núm. OCT
2016
-
Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization
Frontiers in Pharmacology, Vol. 7, Núm. MAR
-
Two affinity sites of the cannabinoid subtype 2 receptor identified by a novel homogeneous binding assay
Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 3, pp. 580-587
2015
-
A labor and cost effective next generation sequencing of PKHD1 in autosomal recessive polycystic kidney disease patients
Gene, Vol. 561, Núm. 1, pp. 165-169
-
The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients
Journal of Human Genetics, Vol. 60, Núm. 5, pp. 273-276
2014
-
A labor- and cost-effective non-optical semiconductor (Ion Torrent) next-generation sequencing of the SLC12A3 and CLCNKA/B genes in Gitelman's syndrome patients
Journal of Human Genetics, Vol. 59, Núm. 7, pp. 376-380
-
Effect of the FTO rs9930506 Polymorphism on the Main Comorbidities of the Cardiorenal Metabolic Syndrome in an Elderly Spanish Cohort
CardioRenal Medicine, Vol. 4, Núm. 2, pp. 82-87
-
Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients
Gene, Vol. 538, Núm. 1, pp. 195-198
2013
-
A CLCNKA polymorphism (rs10927887; p.Arg83Gly) previously linked to heart failure is associated with the estimated glomerular filtration rate in the RENASTUR cohort
Gene, Vol. 527, Núm. 2, pp. 670-672
-
A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients
Pharmacogenetics and Genomics, Vol. 23, Núm. 8, pp. 445-448
2012
-
Resequencing the whole MYH7 gene (including the intronic, promoter, and 3′ UTR sequences) in hypertrophic cardiomyopathy
Journal of Molecular Diagnostics, Vol. 14, Núm. 5, pp. 518-524
2011
-
El complejo escenario de las alteraciones de metabolismo óseo y mineral en la enfermedad renal crónica
Nefrologia, Vol. 31, Núm. 5, pp. 514-519
-
Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))
Clinical Chemistry and Laboratory Medicine
-
Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
Clinical Chemistry and Laboratory Medicine, Vol. 49, Núm. 5, pp. 825-833